Portable Mass Spectrometer

Rapid On-Site Analysis with Portable MS Technology

Cell Mini MS System utilizes an in-situ ionization kit to enable rapid on-site detection, featuring ultra-fast analysis speed and user-friendly pre-processing. The portable mass spectrometer is ideal for rapid detection applications across biomedical research, clinical diagnostics, public security investigations, and beyond. Equipped with high-performance analytical capabilities, this portable mass spec accurately identifies analyte content and molecular structures. By integrating DAPI technology with an atmospheric pressure ionization source and in-situ ionization kit, it delivers exceptional sensitivity, precision, and determinacy—achieving lab-grade performance in an ultra-compact design.

With one-touch intelligent operation, it eliminates complex sample pre-treatment and time-consuming separation procedures, accommodating a wide spectrum of analyte types to meet diverse analytical needs. This innovation provides end-users with simple, fast, and real-time in-situ chemical analysis of complex samples, solidifying its role as a leading solution for field-deployable mass spectrometry.

Key Features

Specifications

Applications

• Clinical toxin screening at point-of-care
• Emergency chemical identification for first responders
• Pharmaceutical QA/QC in manufacturing facilities
• Environmental contaminant mapping

Case Study

Clinical Diagnosis-Intraoperative diagnosis of lDH mutations in glioma

The mutated lDH protein can reduce α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG), and the abnormally produced 2-HG can promote tumorigenesis. 2-HG has the characteristics of specificity and inertness, and is suitable for mass spectrometry detection. lt has unique advantages for rapid intraoperative diagnosis of lDH mutations and boundary judgment.

• More efficient: lDH mutation results can beobtained in only 1.5 minutes
• More accurate: sensitivity and specificity areboth higher than 90%
• More information: More biological informationcan be obtained by testing directly with freshtissue

Precision Medicine-Blood concentration monitoring

Voriconazole, one of the second-generation triazoles, is the first-line treatment for invasive fungal infections, but it has a narrow therapeutic window, nonlinear pharmacokinetics, and significant inter-individual variability. Blood concentration monitoring has been widely recommended to guide voriconazole dose adjustment and optimize clinical treatment.

• Convenience: no complicated pre-processing required, operation is more convenient
• Fast: only 5 minutes from sample collection to report acquisition
• Accurate: high consistency with LC-MS detection

How to apply for demo?

Please call 301-890-6420 or send an email to sales@lifesct.com for demo